Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

6.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
6.0K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.6K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydrogels in Autoimmune Disease: A Comprehensive Review of Current Research and Clinical Potentials.

International journal of nanomedicine·2026
Same author

Aptamer-Directed Assembly of NSET Microneedle Patch for Early Detection of Acute Kidney Injury Facilitated by Deep Learning-Enabled Target Signal Extraction.

ACS sensors·2026
Same author

Ratiometric near-infrared fluorescent probe for imaging Peroxynitrite fluxes in rheumatoid arthritis and drug-induced liver injury models.

Analytica chimica acta·2026
Same author

Unlocking Azulene Functionalization via Strain-Induced Azulyne Intermediates.

Journal of the American Chemical Society·2026
Same author

Targeting PHKA2 by Thymol alleviates sepsis induced cardiomyocyte pyroptosis via FOXA1/KLF4-mediated macrophage polarization.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Molecular hydrogen in cancer therapy: Bioactive materials for tumor-targeted delivery and in situ generation.

Journal of controlled release : official journal of the Controlled Release Society·2026

Related Experiment Video

Updated: Mar 26, 2026

Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research
10:11

Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research

Published on: October 27, 2023

1.6K

Mesenchymal stem cells for treating ocular surface diseases.

Liyun Zhang1, Vivien Jane Coulson-Thomas2, Tarsis Gesteira Ferreira3

  • 1Department of Ophthalmology, University of Cincinnati, Ohio, USA. LZHANG98@JHMI.EDU.

BMC Ophthalmology
|January 29, 2016
PubMed
Summary

Mesenchymal stem cells (MSC) show promise for regenerative medicine, particularly in treating corneal diseases. Standardization of MSC isolation and expansion is crucial for advancing cell therapies for ocular surface conditions.

More Related Videos

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
11:22

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

18.0K
Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells
10:07

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells

Published on: October 24, 2018

8.3K

Related Experiment Videos

Last Updated: Mar 26, 2026

Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research
10:11

Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research

Published on: October 27, 2023

1.6K
Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
11:22

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

18.0K
Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells
10:07

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells

Published on: October 24, 2018

8.3K

Area of Science:

  • Regenerative Medicine
  • Ophthalmology
  • Cell Therapy

Background:

  • Mesenchymal stem cells (MSC) are a promising cell therapy due to their differentiation and immunosuppressive properties.
  • MSC are being investigated for treating various diseases, including corneal conditions, with ongoing clinical trials.

Purpose of the Study:

  • To review recent advances in using MSC for treating ocular surface diseases.
  • To highlight the potential of MSC in regenerative medicine for eye conditions.

Main Methods:

  • Review of existing studies on MSC differentiation and efficacy in corneal disease models.
  • Analysis of current challenges and future directions in MSC-based ocular therapies.

Main Results:

  • MSC can differentiate into corneal cells (keratocytes in vitro/in vivo, epithelial cells in vitro).
  • Efficacy of MSC for corneal endothelial defects requires further unequivocal establishment.
  • Diversity in MSC isolation/expansion protocols hinders treatment assessment.

Conclusions:

  • MSC hold significant potential for treating ocular surface diseases.
  • International standards for MSC isolation and characterization are needed.
  • Further research is essential to optimize MSC-based therapeutic regimens for corneal conditions.